Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
31.90
-0.82 (-2.51%)
Sep 10, 2025, 2:50 PM - Market open
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.14 billion as of September 10, 2025. Its market cap has decreased by -52.51% in one year.
Market Cap
4.14B
Enterprise Value
2.69B
1-Year Change
-52.51%
Ranking
Category
Stock Price
$31.90
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.14B, an increase of 200.11%. That is a compound annual growth rate of 23.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 4.25B | -58.37% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |